Salt Lake City,
Utah - On July 25, 2006, Utah Medical Products, Inc. (Nasdaq:
UTMD) received a Nasdaq Staff Deficiency Letter. The NASDAQ letter followed
the resignation of Dr. Stephen W. Bennett from the board of directors on
July 11, 2006.
On February 22, 2007 UTMD announced that its board of directors had elected
Dr. James H. Beeson to fill the vacancy on its board of directors for the
unexpired term of Dr. Stephen W. Bennett, and serve as a member of the audit
committee as one of three independent directors on the board.
Today UTMD received a letter from the Nasdaq confirming, “Staff has
determined that the Company [UTMD] complies with the Rule [Marketplace Rules
4350(c) and 4350(d)(2)] and this matter is now closed.”
UTMD expects that Nasdaq and all other financial reporting agencies will now
remove the “non-compliance indication” which has been attached to its stock
symbol since July 2006.
Utah Medical Products, Inc., with particular interest in health care for
women and their babies, develops, manufactures, assembles and markets a
broad range of disposable and reusable specialty medical devices designed
for better health outcomes for patients and their care-providers. For more
information about Utah Medical Products, Inc., visit UTMD's website at